News

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...
In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...
Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...